TRI-MOXI-VANC

Serial Number 87335606
606

Registration Progress

Application Filed
Feb 14, 2017
Under Examination
Jul 31, 2018
Approved for Publication
Jun 5, 2018
Published for Opposition
Jun 5, 2018
Registered

Trademark Image

TRI-MOXI-VANC

Basic Information

Serial Number
87335606
Filing Date
February 14, 2017
Published for Opposition
June 5, 2018
Abandonment Date
March 4, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 4, 2019
Classes
005

Rights Holder

IMPRIMIS PHARMACEUTICALS, INC.

03
Address
12264 El Camino Real, Suite 350
San Diego, CA 92130

Ownership History

IMPRIMIS PHARMACEUTICALS, INC.

Original Applicant
03
San Diego, CA

IMPRIMIS PHARMACEUTICALS, INC.

Owner at Publication
03
San Diego, CA

Legal Representation

Attorney
Antony M. Novom

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

21 events
Date Code Type Description Documents
Mar 4, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 4, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 31, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 5, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 5, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 16, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 3, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 25, 2017 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Apr 17, 2017 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 17, 2017 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 17, 2017 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Mar 28, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 28, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 28, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 24, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 24, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 24, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 16, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 14, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 21, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 17, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical compositions for treating ophthalmological diseases, disorders, or pathologies
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005